NEUMORA THERAPEUTICS INC (NMRA) Stock Earnings & Estimates
NASDAQ:NMRA - US6409791000 - Common Stock
1.73 USD
-0.03 (-1.7%)
1.73 USD
0 (0%)
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | N/A | N/A | N/A 211.22% | N/A 608.51% | N/A 183.51% | N/A 137.14% | N/A 56.88% | N/A 47.41% | |||||||
| EBITDA YoY % growth | -20K | -25.39M -126,850.00% | -79.78M -214.22% | -122.28M -53.27% | -187.526M -53.36% | -262.833M -40.16% | N/A 6.08% | N/A 39.67% | N/A -2.74% | N/A -51.47% | N/A 29.45% | N/A 88.33% | N/A 408.02% | N/A 93.24% | |
| EBIT YoY % growth | -20K | -25.5M -127,400.00% | -80.32M -214.98% | -122.87M -52.98% | -188.194M -53.17% | -263.464M -40.00% | N/A 2.49% | N/A 20.61% | N/A -6.72% | N/A 15.84% | N/A 67.07% | N/A 499.86% | N/A 102.98% | N/A 65.62% | |
| Operating Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EPS YoY % growth | N/A | N/A | N/A | N/A | N/A | -1.53 14.22% | N/A 5.62% | N/A 24.32% | N/A 3.87% | N/A 15.73% | N/A 83.64% | N/A 969.72% | N/A 75.98% | N/A 56.60% |
All data in USD
| Q3 / 25 | Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.34 24.23% | -0.34 7.84% | -0.34 19.86% | -0.29 11.39% | -0.26 24.22% | -0.25 26.21% |
| Revenue Q2Q % growth | ||||||
| EBITDA Q2Q % growth | -58.14M 23.67% | -59.16M 5.03% | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -58.237M 24.02% | -57.266M 8.99% | -45.696M 35.58% | -42.84M 20.73% | -34.68M 40.45% | -28.56M 50.13% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | -0.33 10.81% | -0.38 | 0.05 | 12.16% |
| Q1 2025 Q2Q % growth | -0.42 -23.53% | -0.38 | -0.04 | -10.01% |
| Q4 2024 Q2Q % growth | -0.37 47.89% | -0.46 | 0.09 | 18.71% |
| Q3 2024 Q2Q % growth | -0.45 60.53% | -0.40 | -0.05 | -13.12% |
| Q2 2024 Q2Q % growth | -0.37 | -0.38 | 0.01 | 2.34% |
| Q1 2024 Q2Q % growth | -0.34 | -0.35 | 0.01 | 2.53% |
| Q4 2023 Q2Q % growth | -0.71 | -0.56 | -0.15 | -26.56% |
| Q3 2023 Q2Q % growth | -1.14 | -0.37 | -0.77 | -208.32% |
| Period | Reported | Estimate | Difference | Surprise |
|---|
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 6.27% | 20.41% | -0.52% | 5.54% |
| Revenue | N/A | N/A | N/A | N/A |